FIELD: medicine.
SUBSTANCE: pharmaceutical unit dosage form for treatment or prevention of cardiovascular episodes contains therapeutic amount of: antagonist of β-adrenergic receptor, diuretic or both; an agent lowering cholesterol level; an inhibitor of renin-angiotensin system; and aspirin. The pharmaceutical unit dosage form can be made in a two-layered tableted form. The first layer thereof contains simvastatin and aspirin, the second layer contains athenolol and lisinopril, or the second layer contains hydrichlorothiazide and lisinopril.
EFFECT: according to the invention pharmaceutical unit dosage form combines a number of drugs for oral intake once a day that improves compliance by the patient with prescribed regimen due to elimination of inconveniences related to intake of several doses of drugs during the day, and reduces probability of missing the dose.
24 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CARDIOVASCULAR DISEASES | 2011 |
|
RU2491070C2 |
| STABLE PHARMACEUTICAL PREPARATION CONTAINING AMLODIPINE BENZYLATE AND ATENOLOL | 1998 |
|
RU2188636C2 |
| PHARMACOLOGICAL COMPOSITION WITH SWELLING COATING | 2004 |
|
RU2375048C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING HMG-CoA REDUCTASE INHIBITOR AND ACE INHIBITOR | 2016 |
|
RU2750934C2 |
| APPLICATION OF SUBSTITUTED CYANOPYROLIDINES AND COMBINED PREPARATIONS CONTAINING THEM FOR TREATMENT OF LIPIDEMIA AND ASSOCIATED DISEASES | 2003 |
|
RU2362555C2 |
| RENIN-ANGIOTENSIN SYSTEM INHIBITORS APPLICATION FOR PREVENTING CARDIOVASCULAR DISEASE MANIFESTATIONS | 2000 |
|
RU2276997C2 |
| CAPSULE AND DRUG PREPARATION FOR PREVENTING CARDIOVASCULAR DISEASES | 2009 |
|
RU2477123C2 |
| METHOD OF TREATING CARDIOVASCULAR DISEASES | 2012 |
|
RU2570752C2 |
| PHARMACEUTICAL COMPOSITION, CONTAINING CALCIUM SALT OF ROSUVASTATIN | 2012 |
|
RU2602911C2 |
| APPLICATION OF ORGANIC COMPOUNDS | 2005 |
|
RU2426532C2 |
